Publications by authors named "Abidi E"

Article Synopsis
  • - Smoking, especially chronic smoking, poses a significant health risk by increasing the chances of heart-related diseases and causing damage to the heart's structure and function through oxidative stress and endothelial dysfunction.
  • - This study examines how chronic cigarette smoke interacts with the oral contraceptive ethinylestradiol in premenopausal females, revealing that their combination leads to negative changes in heart structure, such as larger left ventricular size and increased heart mass.
  • - Results indicate that this combination triggers an inflammatory response, with elevated inflammatory markers and collagen deposition, suggesting it may lead to heart conditions similar to dilated cardiomyopathy.
View Article and Find Full Text PDF

Background And Objective: Extending a consistent pharmacy antimicrobial stewardship weekend service was a newly implemented initiative. We sought to evaluate the impact of incorporating an Infectious Diseases (ID)-trained clinical pharmacist into an antimicrobial stewardship program (AMS) during weekends.

Results: The number of documented interventions was 451 on 362 patients compared to 115 interventions on 108 patients during the pre-implementation period ( = 0.

View Article and Find Full Text PDF
Article Synopsis
  • In February 2024, a course on cytotaxonomy took place in Pisa, Italy, where scientists used image analysis software to see if different people could give different results when measuring plant cells.
  • They found that people measuring short arms of cell structures might make them look longer than they really are.
  • To get more accurate and consistent measurements, they suggested making a standard way to measure these cell parts.
View Article and Find Full Text PDF

This manuscript presents a proof-of-concept for a generalizable strategy, the full algorithm, designed to estimate disease risk using real-world clinical tabular data systems, such as electronic health records (EHR) or claims databases. By integrating classic statistical methods and modern artificial intelligence techniques, this strategy automates the production of a disease prediction model that comprehensively reflects the dynamics contained within the underlying data system. Specifically, the full algorithm parses through every facet of the data (e.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness of two antibiotics, ceftazidime-avibactam (CZA) and ceftolozane-tazobactam (C/T), in treating multidrug-resistant Pseudomonas aeruginosa infections in patients on renal replacement therapy.
  • A total of 45 patients were analyzed, with similar clinical cure rates for both CZA (48%) and C/T (60%), and no significant differences in outcomes such as microbiologic cure, recurrence, or 30-day mortality.
  • The results suggest that both antibiotics are equally effective for clinical cure in the studied population, but further research with larger sample sizes is necessary to validate these findings.
View Article and Find Full Text PDF

Purpose: The clinical efficacy and safety of ertapenem use in patients undergoing renal replacement therapies (RRT) are not well-documented. Therefore, we aimed to investigate the safety and efficacy of ertapenem in patients with sepsis secondary to Enterobacterales who are undergoing RRT.

Methods: A retrospective cohort study was conducted on patients who met the inclusion criteria at our hospital between May 2015 and December 2021.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigated the effectiveness of Trimethoprim-sulfamethoxazole (TMP/SMZ) in critically ill patients with infections undergoing renal replacement therapies (RRT), focusing on clinical outcomes such as cure rates and mortality.
  • Out of 45 patients analyzed, only 40% achieved clinical success while 60% failed treatment, with a significantly higher mortality rate (44.4%) in the clinical failure group.
  • The research found that higher daily doses of TMP/SMZ at therapy initiation were linked to better clinical outcomes, highlighting the importance of dosage in treatment effectiveness for these patients.
View Article and Find Full Text PDF

Apixaban has been increasingly utilized for various FDA-approved indications, including stroke prevention and venous thromboembolism (VTE) treatment in patients with end stage kidney disease (ESKD) on hemodialysis. However, the safety and efficacy of its use in this population is not well established. Hence, the purpose of this study is to evaluate the safety and effectiveness of apixaban by examining outcomes in this population.

View Article and Find Full Text PDF

Background: Data on P2Y12 inhibitors responsiveness from the middle east is scarce. We sought to investigate patient responsiveness to P2Y12 inhibitors within a cohort of major races that characterize the UAE population. The secondary objective was to assess risk factors for hyper and hypo-responsiveness in this population.

View Article and Find Full Text PDF

An asymmetric dual-grating gate bilayer graphene-based field effect transistor (ADGG-GFET) with an integrated bowtie antenna was fabricated and its response as a Terahertz (THz) detector was experimentally investigated. The device was cooled down to 4.5 K, and excited at different frequencies (0.

View Article and Find Full Text PDF

Background And Aim: Little is known about the burden of cardiorenal syndrome (CRS) and cardiorenal anemia syndrome (CRAS) in the Middle East Region. Furthermore, whether the occurrence rates of CRAS differ across heart failure (HF) phenotypes is not widely investigated. We aimed to examine the prevalence of CRS and CRAS in patients with HF, compare characteristics of patients with CRAS-HFrEF vs.

View Article and Find Full Text PDF

Unlabelled: Ceftolozane-tazobactam (C/T) recommended dosing in patients undergoing renal replacement therapies (RRT) is lacking evidence. The objective of this study was to evaluate the clinical outcomes of C/T dosing in patients on RRT.

Materials And Methods: A retrospective descriptive study conducted at our institution between May 1, 2017, and March 15, 2022.

View Article and Find Full Text PDF

There has been a substantial increase in the use of extracorporeal membrane oxygenation (ECMO) support in critically ill adults. Understanding the complex changes that could affect drugs' pharmacokinetics (PK) and pharmacodynamics (PD) is of suitable need. Therefore, critically ill patients on ECMO represent a challenging clinical situation to manage pharmacotherapy.

View Article and Find Full Text PDF

Introduction: The suggested dose of ceftazidime-avibactam (CEF/AVI) in patient with multidrug resistant organisms and utilizing renal replacement therapies (RRTs) is not validated in clinical studies. The objective of this study was to evaluate the microbiologic cure of bacteremia and pneumonia using the recommended CEF/AVI dosing in patients utilizing RRT.

Methods: A retrospective observational study conducted at our institution between September 15, 2018 and March 15, 2022.

View Article and Find Full Text PDF

Background: Whether cigarette smoking affects the heart post-myocardial infarction (MI) in a sex-dependent way remains controversial. Using a mouse model, we investigated cardiac remodeling under the influence of acute cigarette smoke (CS) exposure following ischemic injury in both sexes.

Methods: Ten cigarettes were smoked twice daily for 2 weeks followed by MI and then 1 additional week post permanent LAD ligation.

View Article and Find Full Text PDF

Elevated concentrations of interleukin-6 have been demonstrated to be an important key factor in COVID-19 host immune impairment. It represents an important prognostic factor of harm associated with COVID-19 infection by stimulating a vigorous proinflammatory response, leading to the so-called "cytokine storm". Therefore, immunomodulatory interventions targeting interleukin-6 receptor antagonism have been investigated as potential treatments to counterbalance the host immune dysregulation and to support the advantageous effects of corticosteroids.

View Article and Find Full Text PDF

Ranolazine was approved by the US Food and Drug Administration as an antianginal drug in 2006, and has been used since in certain groups of patients with stable angina. The therapeutic action of ranolazine was initially attributed to inhibitory effects on fatty acids metabolism. As investigations went on, however, it developed that the main beneficial effects of ranolazine arise from its action on the late sodium current in the heart.

View Article and Find Full Text PDF

Desmoteplase is a bat (Desmodus rotundus) saliva-derived fibrinolytic enzyme resembling a urokinase and tissue plasminogen activator. It is highly dependent on fibrin and has some neuroprotective attributes. Intravenous administration of desmoteplase is safe and well tolerated in healthy subjects.

View Article and Find Full Text PDF

Myocardial infarction (MI) is the leading cause of mortality worldwide. Interleukin (IL)-33 (IL-33) is a cytokine present in most cardiac cells and is secreted on necrosis where it acts as a functional ligand for the ST2 receptor. Although IL-33/ST2 axis is protective against various forms of cardiovascular diseases, some studies suggest potential detrimental roles for IL-33 signaling.

View Article and Find Full Text PDF

Multiple clinical studies documented renal damage in chronic cigarette smokers (CS) irrespective of their age and gender. Premenopausal female smokers are known to exert a certain cardiovascular and renal protection with undefined mechanisms. Given the multiple demographic variables within clinical studies, this experimental study was designed to be the first to assess whether gender-biased CS-induced kidney damage truly exists between premenopausal female and age-matched C57Bl6J male mice when compared to their relative control groups.

View Article and Find Full Text PDF

Despite increased social awareness, marketing restraints, tobacco taxation, and available smoking cessation rehab programs, active and passive smoking remain a worldwide challenging epidemic and a key risk factor for cardiovascular diseases development. Although cardiovascular (CV) protection is more pronounced in women than in men due to estrogenic effects, tobacco cigarette smoking exposure seems to alter this protection by modulating estrogen actions via undefined mechanisms. Premenopausal cigarette smoking women are at higher risk of adverse CV effects than non-smokers.

View Article and Find Full Text PDF

Introduction And Purpose: In hospitals, the use of medical instruments and products containing mercury and the management of mercury waste (MW) collected are regulated in developed countries. In Tunisia, MW end up in landfill and no strategy has so far been adopted. The objective of this study was to quantify MW in two university hospitals in Tunis and to indicate the elimination pathways used and to propose certain recommendations.

View Article and Find Full Text PDF

Diabetes is a global epidemic and a leading cause of death with more than 422 million patients worldwide out of whom around 392 million alone suffer from type 2 diabetes (T2D). Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are novel and effective drugs in managing glycemia of T2D patients. These inhibitors gained recent clinical and basic research attention due to their clinically observed cardiovascular protective effects.

View Article and Find Full Text PDF

Cigarette smoking (S) is a risk factor for progressive chronic kidney disease, renal dysfunction, and renal failure. In this study, the effect of smoking on kidney function was investigated in a mouse model of myocardial infarction (MI) using 4 groups: control (C), smoking (S), MI, and S+MI. Histological analysis of S+MI group showed alterations in kidney structure including swelling of the proximal convoluted tubules (PCTs), thinning of the epithelial lining, focal loss of the brush border of PCTs, and patchy glomerular retraction.

View Article and Find Full Text PDF

Passive and active chronic cigarette smoking (CS) remains an international epidemic and a key risk factor for cardiovascular disease (CVD) development. CS-induced cardiac damage is divided into two major and interchangeable mechanisms: (1) direct adverse effects on the myocardium causing smoking cardiomyopathy and (2) indirect effects on the myocardium by fueling comorbidities such as atherosclerotic syndromes and hypertension that eventually damage and remodel the heart. To date, our understanding of cardiac remodeling following acute and chronic smoking exposure is not well elucidated.

View Article and Find Full Text PDF